Microevolution of BCG substrains
Tuberculosis was, and still is, one of the main causes of morbidity and mortality in the world. Thus it still remains a public health priority. Nonetheless, without a newly developed vaccine, it is rather unlikely to be easily resolved. The only available vaccine against tuberculosis (BCG) has been...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Index Copernicus International S.A.
2016-12-01
|
Series: | Postępy Higieny i Medycyny Doświadczalnej |
Subjects: | |
Online Access: | http://phmd.pl/gicid/01.3001.0009.6903 |
id |
doaj-aea8dfde420d41ffacda2b898c6db594 |
---|---|
record_format |
Article |
spelling |
doaj-aea8dfde420d41ffacda2b898c6db5942020-11-24T22:46:20ZengIndex Copernicus International S.A.Postępy Higieny i Medycyny Doświadczalnej0032-54491732-26932016-12-01701259126610.5604/01.3001.0009.690301.3001.0009.6903Microevolution of BCG substrainsKatarzyna Krysztopa‑Grzybowska0Anna Lutyńska1Zakład Badania Surowic i Szczepionek, Narodowy Instytut Zdrowia Publicznego – Państwowy Zakład Higieny w WarszawieZakład Badania Surowic i Szczepionek, Narodowy Instytut Zdrowia Publicznego – Państwowy Zakład Higieny w WarszawieTuberculosis was, and still is, one of the main causes of morbidity and mortality in the world. Thus it still remains a public health priority. Nonetheless, without a newly developed vaccine, it is rather unlikely to be easily resolved. The only available vaccine against tuberculosis (BCG) has been used for nearly 100 years. Currently a variety of BCG substrains are used by many manufacturers in the world. All these substrains were obtained from a single parental strain of Mycobacterium bovis. Attempts to explain the complete mechanisms of attenuation, as well as tracing the microevolution resulting from the different distribution time and conditions of production of BCG vaccines in the different parts of the world, might explain the differences in the observed efficacy of vaccines produced with different substrains. The most important marker associated with attenuation of virulent M. bovis is the loss of the RD1 region observed in all BCG substrains. Among other attenuation markers, still not completely identified, accumulation of SNP mutations seems to be an important one. The different number of passages and culture conditions of the parental vaccine strain have led to there being about 50 different sister vaccine BCG substrains throughout the world. Among them, there are “early strains”, distributed until 1927, and “later strains” with the RD2 deletion obtained during 1927‑1961. It has also been found that 22 regions containing 52 genes were lost during the distribution of sister substrains during the period 1924‑1966. Genetic differences due to selection pressure, revealing specific microevolutionary traits, may explain the variability in immunogenicity and residual virulence of each vaccine BCG substrain. http://phmd.pl/gicid/01.3001.0009.6903szczepionka przeciw gruźlicyBCGpodszczepy BCGatenuacjaTB vaccineBCG |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Katarzyna Krysztopa‑Grzybowska Anna Lutyńska |
spellingShingle |
Katarzyna Krysztopa‑Grzybowska Anna Lutyńska Microevolution of BCG substrains Postępy Higieny i Medycyny Doświadczalnej szczepionka przeciw gruźlicy BCG podszczepy BCG atenuacja TB vaccine BCG |
author_facet |
Katarzyna Krysztopa‑Grzybowska Anna Lutyńska |
author_sort |
Katarzyna Krysztopa‑Grzybowska |
title |
Microevolution of BCG substrains |
title_short |
Microevolution of BCG substrains |
title_full |
Microevolution of BCG substrains |
title_fullStr |
Microevolution of BCG substrains |
title_full_unstemmed |
Microevolution of BCG substrains |
title_sort |
microevolution of bcg substrains |
publisher |
Index Copernicus International S.A. |
series |
Postępy Higieny i Medycyny Doświadczalnej |
issn |
0032-5449 1732-2693 |
publishDate |
2016-12-01 |
description |
Tuberculosis was, and still is, one of the main causes of morbidity and mortality in the world. Thus it still remains a public health priority. Nonetheless, without a newly developed vaccine, it is rather unlikely to be easily resolved. The only available vaccine against tuberculosis (BCG) has been used for nearly 100 years. Currently a variety of BCG substrains are used by many manufacturers in the world. All these substrains were obtained from a single parental strain of Mycobacterium bovis. Attempts to explain the complete mechanisms of attenuation, as well as tracing the microevolution resulting from the different distribution time and conditions of production of BCG vaccines in the different parts of the world, might explain the differences in the observed efficacy of vaccines produced with different substrains. The most important marker associated with attenuation of virulent M. bovis is the loss of the RD1 region observed in all BCG substrains. Among other attenuation markers, still not completely identified, accumulation of SNP mutations seems to be an important one. The different number of passages and culture conditions of the parental vaccine strain have led to there being about 50 different sister vaccine BCG substrains throughout the world. Among them, there are “early strains”, distributed until 1927, and “later strains” with the RD2 deletion obtained during 1927‑1961. It has also been found that 22 regions containing 52 genes were lost during the distribution of sister substrains during the period 1924‑1966. Genetic differences due to selection pressure, revealing specific microevolutionary traits, may explain the variability in immunogenicity and residual virulence of each vaccine BCG substrain.
|
topic |
szczepionka przeciw gruźlicy BCG podszczepy BCG atenuacja TB vaccine BCG |
url |
http://phmd.pl/gicid/01.3001.0009.6903 |
work_keys_str_mv |
AT katarzynakrysztopagrzybowska microevolutionofbcgsubstrains AT annalutynska microevolutionofbcgsubstrains |
_version_ |
1725685274069958656 |